BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12690203)

  • 1. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
    Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
    Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
    Zhu Q; Yao J; Wani G; Wani MA; Wani AA
    J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p53 degradation by Mdm2 acetylation.
    Wang X; Taplick J; Geva N; Oren M
    FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p300/MDM2 complexes participate in MDM2-mediated p53 degradation.
    Grossman SR; Perez M; Kung AL; Joseph M; Mansur C; Xiao ZX; Kumar S; Howley PM; Livingston DM
    Mol Cell; 1998 Oct; 2(4):405-15. PubMed ID: 9809062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
    Honda R; Tanaka H; Yasuda H
    FEBS Lett; 1997 Dec; 420(1):25-7. PubMed ID: 9450543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
    Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.
    Jin Y; Zeng SX; Lee H; Lu H
    J Biol Chem; 2004 May; 279(19):20035-43. PubMed ID: 14769800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
    Wadgaonkar R; Collins T
    J Biol Chem; 1999 May; 274(20):13760-7. PubMed ID: 10318779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function.
    Thomas A; White E
    Genes Dev; 1998 Jul; 12(13):1975-85. PubMed ID: 9649502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.
    Li Z; Day CP; Yang JY; Tsai WB; Lozano G; Shih HM; Hung MC
    Cancer Res; 2004 Dec; 64(24):9080-5. PubMed ID: 15604276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
    Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
    Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    Fang S; Jensen JP; Ludwig RL; Vousden KH; Weissman AM
    J Biol Chem; 2000 Mar; 275(12):8945-51. PubMed ID: 10722742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; LaĆ­n S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
    Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
    Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.
    O'Connor MJ; Zimmermann H; Nielsen S; Bernard HU; Kouzarides T
    J Virol; 1999 May; 73(5):3574-81. PubMed ID: 10196247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.